These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PIN1 expression contributes to hepatic carcinogenesis. Pang RW; Lee TK; Man K; Poon RT; Fan ST; Kwong YL; Tse E J Pathol; 2006 Sep; 210(1):19-25. PubMed ID: 16841372 [TBL] [Abstract][Full Text] [Related]
4. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Ryo A; Uemura H; Ishiguro H; Saitoh T; Yamaguchi A; Perrem K; Kubota Y; Lu KP; Aoki I Clin Cancer Res; 2005 Oct; 11(20):7523-31. PubMed ID: 16243827 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. He J; Zhou F; Shao K; Hang J; Wang H; Rayburn E; Xiao ZX; Lee SW; Xue Q; Feng XL; Shi SS; Zhang CY; Zhang S Lung Cancer; 2007 Apr; 56(1):51-8. PubMed ID: 17275947 [TBL] [Abstract][Full Text] [Related]
6. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma. Han Y; Tian H; Chen P; Lin Q Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994 [TBL] [Abstract][Full Text] [Related]
7. RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells. Jin J; Zhang Y; Li Y; Zhang H; Li H; Yuan X; Li X; Zhou W; Xu B; Zhang C; Zhang Z; Zhu L; Chen X Neoplasma; 2013; 60(1):92-100. PubMed ID: 23067222 [TBL] [Abstract][Full Text] [Related]
8. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. Luo ML; Gong C; Chen CH; Lee DY; Hu H; Huang P; Yao Y; Guo W; Reinhardt F; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP Cancer Res; 2014 Jul; 74(13):3603-16. PubMed ID: 24786790 [TBL] [Abstract][Full Text] [Related]
9. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3. Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705 [TBL] [Abstract][Full Text] [Related]
10. Expression of Pin1 mRNA in non-small-cell lung cancer patients. Ai Z; Zhang W; Luo W; Huang L; Pan Y Asian Cardiovasc Thorac Ann; 2009 Apr; 17(2):157-61. PubMed ID: 19592546 [TBL] [Abstract][Full Text] [Related]
11. The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells. Khanal P; Kim G; Yun HJ; Cho HG; Choi HS Mol Carcinog; 2013 Oct; 52(10):813-23. PubMed ID: 22549912 [TBL] [Abstract][Full Text] [Related]
12. Expression and significance of Pin1 mRNA in circulating mononuclear cells from non-small cell lung cancer patients during perioperative period. Ai ZH; Zhang WX; Luo WJ; Huang LJ; Pan Y Ai Zheng; 2009 Mar; 28(3):268-73. PubMed ID: 19619441 [TBL] [Abstract][Full Text] [Related]
13. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136 [TBL] [Abstract][Full Text] [Related]
14. Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Lu KP; Suizu F; Zhou XZ; Finn G; Lam P; Wulf G Mol Carcinog; 2006 Jun; 45(6):397-402. PubMed ID: 16652378 [TBL] [Abstract][Full Text] [Related]
15. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1. Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161 [TBL] [Abstract][Full Text] [Related]
16. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319 [TBL] [Abstract][Full Text] [Related]
17. Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Fukuchi M; Fukai Y; Kimura H; Sohda M; Miyazaki T; Nakajima M; Masuda N; Tsukada K; Kato H; Kuwano H Int J Oncol; 2006 Aug; 29(2):329-34. PubMed ID: 16820873 [TBL] [Abstract][Full Text] [Related]
18. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers. Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364 [TBL] [Abstract][Full Text] [Related]
19. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness. Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L Tumori; 2016; 102(2):144-9. PubMed ID: 26917410 [TBL] [Abstract][Full Text] [Related]
20. Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma. Leung KW; Tsai CH; Hsiao M; Tseng CJ; Ger LP; Lee KH; Lu PJ Oncol Rep; 2009 Apr; 21(4):1097-104. PubMed ID: 19288014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]